EpicResearchのプロフィール
EpicResearch

名:
Epic Research
プロフィール:
Epic Research is an ISO 9001-2008 certified company and a leading financial services provider with presence in global capital markets.Epic has offices and representatives in U.S.A., Singapore, Australia and Middle East.
We provide stock recommendation for SGX , KLSE Forex, Commodity ,Comex etc.
トレードスタイル:
設定されていない。
モットー:
体験: 3~5年
場所:
バウチャー: 0
登録されて: Jan 24 2015 at 09:21
Blocked Users: 0
チャート
システム
このユーザーは、現在のすべてのシステムを共有することはありません。
EpicResearch's Feed
EpicResearch
EpicResearch
SGX is reducing the standard board lot size from 1,000 units to 100 units in January 2015. The reduction will apply to ordinary shares (including shares traded on GlobalQuote), real estate investment trusts, business trusts, company warrants, structured warrants and extended settlement contracts. Existing board lot sizes of 100 or less units will remain unchanged. The board lot sizes for existing temporary trading counters (e.g. rights shares) will also remain unchanged.
Jan 24 2015 at 10:38
Producer Price Index (MoM) (4h 39min)
China Gross Domestic Product (YoY) meets...(19 min ago)
EURUSD 1.13774 GBPUSD 1.28606
USDJPY 109.595 USDCAD 1.32649

ツール

コミュニティ

レビュー

ブローカー

プラットフォーム

サポート


Twitter |  Facebook |  サイトマップ  |  利用規約  |   プライバシーポリシー
©2019 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment; do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.